October 3, 2021

KnowNow in the Telegraph

KnowNow has been covered in an exclusive in the Telegraph. The coverage focuses on our partnership with Abingdon Health, one of the largest lateral flow manufactures in Europe. This partnership will allow us to scale up our production to meet the commercial demand for our saliva based COVID-19 infectiousness test.

You can read the full coverage with the link below.

https://www.telegraph.co.uk/news/2021/10/02/works-like-flower-bud-new-covid-test-could-end-need-self-isolate/

Find out more

Register interest to find out more about our saliva based COVID-19 infectiousness test.

view our privacy policy here
Had COVID - 19 symptoms in the last 2 days? Apply here to help us make testing accessible to all.